Objective-To assess the early changes in left ventricular diastolic and systolic fimction due to anthracycline treatment. Design-A prospective study of cardiac function by radionucide angiography in adults before and one month after the end of anthracycline treatment. Patients-60 patients without cardiac disease treated with chemotherapy containing anthracycline. Methods-Cardiac function was assessed by radionuclide measurement throughout treatment. Ejection fraction, peak ejection rate, time to peak ejection rate, filling rate, and time to peak filling rate were measured before and after treatment. To normalise radionucide measurements of the left ventricular diastolic function the ratio of the filling rate to the ejection fraction and the ratio of the filling rate to the peak ejection rate were calculated. Results-No patient developed symptomatic congestive cardiac failure. The ejection fraction decreased from 58% (5%) to 55% (6%) (P < 0.001), the peak ejection rate fell from 2-99 (0.41) to 2-77 (0.41) ofthe end diastolic volume per second (P < 0.001), and the peak filling rate from 2*71 (0.47) to 2*55 (0 44) of the end diastolic volume per second (P < 0. 
filling rate, and time to peak filling rate were measured before and after treatment. To normalise radionucide measurements of the left ventricular diastolic function the ratio of the filling rate to the ejection fraction and the ratio of the filling rate to the peak ejection rate were calculated. Results-No patient developed symptomatic congestive cardiac failure. The ejection fraction decreased from 58% (5%) to 55% (6%) (P < 0.001), the peak ejection rate fell from 2-99 (0.41) to 2-77 (0.41) ofthe end diastolic volume per second (P < 0.001), and the peak filling rate from 2*71 (0.47) to was used. The camera had an interface with a Sopha P512 computer. Images of 6 million counts were obtained using 32 frames and a 64 x 64 matrix with a pixel size of 2A4 mm.
RR intervals and heart rate (beats/min) were recorded. Cardiac cycles with RR intervals that were not within 10% of the average value were discarded. Left ventricular ejection fraction at rest was determined by manual definition of end diastolic and end systolic regions. The background region was also manually defined outside the end systolic boundary extending around the apex and along the lateral wall of the left ventricle. The first degree derivative curve was calculated by convolution of the curve of left ventricular volume by using a derivative filter of five points. To analyse systolic function we calculated the peak ejection rate, and the time to the peak, and for diastolic function the peak filling rate and the time to the peak. The peak rates were expressed as a fraction of the end diastolic volume (EDV/s) and as a fraction of stroke volume (SV/s). To minimise the contribution of systole to the peak filling rate we also expressed the peak filling rate as a fraction of peak ejection rate. 7 8 Statistics Parameters before and after treatment were compared by the paired Student's t test. The relations of peak filling rate, peak ejection rate, and their ratio to age, heart rate, and left ventricular ejection fraction were determined by calculation of Pearson correlation coefficients. P values of less than 0 05 were considered significant.
Multiple regression analysis was carried out for filling parameters that correlated significantly with age, heart rate, and left ventricular ejection fraction. The standard error of the estimate (SEE) was calculated for each regression to indicate the spread of the results. The fractional standard error was also calculated Peak filling rate (EDV/s) = -0-0222 x age + 0-0204 x heart rate + 0-0420 x ejection fraction -0-2657 (P < 0 001). Peak filling rate (SV/s) = -0-0401 x age + 0-035 x heart rate + 3-9111 (P< 0 001). Ratio of peak filling to peak ejection rate = -0-0074 x age + 1-2841 (P < 0 001).
as SEE/mean, enabling a direct comparison of the goodness of the fit for different parameters. Estimates of error variance for the filling parameters were directly compared. The significance of the variation in ejection fraction versus the variation in the peak filling rate was tested by a x2 test.
Results

BEFORE CHEMOTHERAPY
Before chemotherapy both filling and ejection parameters correlated with heart rate and ejection fraction, whereas only the filling parameters were related to age (table 1). The dependence of the peak filling rate (EDV/s) on heart rate, age, and ejection fraction was described by the multiple regression equation in table 2. In contrast, when peak filling rate was expressed as SV/s it depended only on heart rate and age. Ultimate normalisation of the peak filling rate to peak ejection rate showed a dependence on age only, thus eliminating the contribution of the heart rate and of the ejection fraction (table 2) .
The alteration in diastolic function with age was reflected by a significant negative correlation (P < 0 001) with the normalised filling parameters. Conversely, for the ejection fraction, Pearson correlation coefficient was significant for peak filling rate (r = 0-267, P < 0 05) but not for age (r = 0-245, P = 0 06) and heart rate (r = -0142, P = 0 28). The regression equation before chemotherapy was: ejection fraction = 49-008 + 3-143 x peak filling rate (P < 0 05).
AFTER CHEMOTHERAPY
After chemotherapy heart rate did not change significantly whereas left ejection fraction and peak ejection rate were significantly decreased (P < 0-001 and P < 0.01, respectively). The time to peak ejection rate increased significantly (P < 0 02) (table 3) .
Peak filling rate (EDV/s) showed a significant decrease after chemotherapy (P < 0 01), without modification of the time to reach the peak rate (table 3) . Peak filling rate (SV/s) and the normalised parameter of diastolic function (ratio of peak filling to ejection rates) did not change after chemotherapy (table 3) .
The change in peak filling rate and the change in ejection fraction were significantly correlated (r = 0-466, P < 0 001) (figure 1). The decrease in peak filling rate and the decrease in peak ejection rate were also correlated (r = 0-495, P < 0 001) (figure 2). Forty four patients had a parallel change in ejection fraction and peak filling rate (X2 = 7-42, P < -0 1). Ejection fraction was also dependent Impairment of diastolic function duing short tern anthracycline chemotherapy Our results are similar to those of Lee et al on almost the same number of normal patients in terms of the filling parameters and age, heart rate, and ejection fraction and the dependence of the normalised radionuclide measurements of left ventricular diastolic function on age. 7 We also confirmed the influence of the filling parameters on the left ventricular systolic function before any treatment. This is in accordance with both angiographic studies and studies of isolated cardiac myocytes, which have shown that diastolic function is necessary to maintain systolic performance.9 10 The absence of variation in age and heart rate, which greatly influence the filling parameters, permitted a good study of the relation between changes in diastolic and systolic function.7 Moreover, we did not study patients with hypertension and coronary artery disease as they are known to have abnormalities of relaxation or to have reduced distensibility.9 P < 0.001 
